TCT-587 What if current generation drug-eluting stents were used in the SYNTAX trial? Analysis of the COMPARE and SYNTAX trials 5 year follow-up

Pieter C. Smits; Georgios J. Vlachojannis; Vasim Farooq; Patrick W. Serruys

doi:10.1016/j.jacc.2014.07.651

Related publications

Article2018

TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney, Roxana Mehran, Bimmer E. Claessen, Sabato Sorrentino, Mengdan Liu, Serdar Farhan, Martin B. Leon, Patrick W. Serruys, Pieter C. Smits, Clemens von Birgelen, Ori Ben‐Yehuda, Mahesh V. Madhavan, Björn Redfors, Gregg W. Stone

Journal of the American College of Cardiology

Article2012

TCT-43 Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Friedrich Mohr, Simon Redwood, G E Venn, Antonio Colombo, Michael J. Mack, A. Pieter Kappetein, Marie‐Claude Morice, David R. Holmes, Ted Feldman, Elisabeth Ståhle, Keith D. Dawkins, Patrick W. Serruys

Journal of the American College of Cardiology

Article2004

862-5 Late four-year follow-up from the first-in-man experience after implantation of sirolimus-eluting stents

J. Eduardo Sousa, Alexandre Abizaid, Marco Costa, Amanda G. M. R. Sousa, Fausto Feres, Luiz Alberto Mattos, Ibraim Pinto, Ana C. Seixas, Luiz Fernando Tanajura, Robert Falotico, Jeffrey J. Popma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2007

The Next Generation of Drug-Eluting Stents

Steve Ramcharitar, Sophia Vaina, Patrick W. Serruys

American Journal of Cardiovascular Drugs

Article2015

TCT-164 Causes of Death after Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Complex Coronary Artery Disease: 5-Year follow-up of the SYNTAX trial

Milan Milojevic, Stuart J. Head, Catalina A. Parasca, Patrick W. Serruys, Friedrich‐Wilhelm Mohr, Marie‐Claude Morice, Michael J. Mack, Elisabeth Ståhle, Ted Feldman, Antonio Colombo, Keith D. Dawkins, A. Pieter Kappetein, David R. Holmes

Journal of the American College of Cardiology

TCT-587 What if current generation drug-eluting stents were used in the SYNTAX trial? Analysis of the COMPARE and SYNTAX trials 5 year follow-up

Abstract

Discussion(0)

Related publications

TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

TCT-43 Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

862-5 Late four-year follow-up from the first-in-man experience after implantation of sirolimus-eluting stents

The Next Generation of Drug-Eluting Stents

TCT-164 Causes of Death after Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Complex Coronary Artery Disease: 5-Year follow-up of the SYNTAX trial